(Q36060748)

11 August 2017

1 reference

title

Latest therapies for bipolar disorder. Looking beyond lithium (English)

1 reference

11 August 2017

1 reference

Leslie Citrome

2

0 references

author name string

Joseph F Goldberg

series ordinal

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

11 August 2017

published in

Postgraduate Medicine

1 reference

11 August 2017

volume

117

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

25-6, 29-32, 35-6

1 reference

What is a "mood stabilizer"? An evidence-based response

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Valproate in the treatment of acute mania. A placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Clinical Factors in Lithium Carbonate Prophylaxis Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Depression during mania. Treatment response to lithium or divalproex.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Antidepressant properties of anticonvulsant drugs for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.02.1585

21 January 2018

Identifiers

DOI

10.3810/PGM.2005.02.1585

1 reference

11 August 2017

1 reference